comparemela.com

Latest Breaking News On - Alimera sciences inc - Page 8 : comparemela.com

StockNews com Initiates Coverage on Alimera Sciences (NASDAQ:ALIM)

StockNews.com initiated coverage on shares of Alimera Sciences (NASDAQ:ALIM – Free Report) in a research report sent to investors on Wednesday. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reiterated a buy rating and set a $5.00 target price on shares of Alimera Sciences in a research report on […]

Alimera Sciences (NASDAQ:ALIM) Now Covered by StockNews com

StockNews.com initiated coverage on shares of Alimera Sciences (NASDAQ:ALIM – Free Report) in a research note published on Wednesday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reissued a buy rating and set a $5.00 target price on shares of Alimera Sciences in a research note on Monday, […]

Alimera Sciences: Q3 Earnings Snapshot

ALPHARETTA, Ga. (AP) — ALPHARETTA, Ga. (AP) — Alimera Sciences Inc. (ALIM) on Thursday reported a loss of $1.4 million in its third quarter.

Alimera Sciences Inc (ALIM) Reports Q3 2023 Financial Results

Record net revenue and significant decrease in net loss highlight the quarter

Alimera Sciences to Report Third Quarter 2023 Financial Results on October 26, 2023, and Provide Corporate Update

16.10.2023 - Conference Call to be held the same day at 9:00am Eastern TimeATLANTA, Oct. 16, 2023 (GLOBE NEWSWIRE) - Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and .

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.